Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011:7:777-87.
doi: 10.2147/VHRM.S17207. Epub 2011 Dec 21.

Benefits of once-daily therapies in the treatment of hypertension

Affiliations
Review

Benefits of once-daily therapies in the treatment of hypertension

John M Flack et al. Vasc Health Risk Manag. 2011.

Abstract

In patients with hypertension, 24-hour blood pressure control is the major therapeutic goal. The number of daily doses is one characteristic of an antihypertensive agent that may affect the adequacy of 24-hour control. One measure of therapeutic coverage is the 24-hour trough-to-peak ratio, which determines the suitability of an agent for once-daily administration. The closer an agent is to a 100% trough-to-peak ratio, the more uniform the 24-hour coverage and therefore blood pressure control. High trough-to-peak ratio, long-acting antihypertensive medications lower blood pressure more gradually, which reduces the likelihood of adverse events attributable to abrupt drug action that occurs with shorter-acting agents. In hypertension, the natural diurnal variation of blood pressure may be altered, including elevated nighttime pressures. An optimal once-daily hypertension therapy would not only lower blood pressure but also normalize any blunted circadian variations in blood pressure. The benefits of once-daily agents with sustained therapeutic coverage may also be explained, in part, by increased patient adherence to simpler regimens as well as lower loss of blood pressure control during virtually inevitable intermittent noncompliance. Studies have demonstrated that once-daily antihypertensive agents have the highest adherence compared with twice-daily or multiple daily doses, including greater adherence to the prescribed timing of doses.

Keywords: adherence; blood pressure control; therapeutic coverage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood pressure responses during a steady-state 24-hour dose interval for an agent with an acceptable (75%) trough-to-peak ratio (A) and an agent with an unacceptable (45%) trough-to-peak ratio (B). Note: Adapted with permission from Meredith. Abbreviations: P, peak; T, trough.
Figure 2
Figure 2
Placebo-corrected blood pressure responses beyond a 24-hour dosing interval for two antihypertensive agents: one with a high trough-to-peak ratio and one with a lower trough-to-peak ratio. Note: Adapted with permission from Meredith and Elliott.

Similar articles

Cited by

References

    1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–1252. - PubMed
    1. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780–800. - PubMed
    1. Zannad F. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs. J Hypertens Suppl. 1995;13(2):S109–112. - PubMed
    1. Meredith PA, Elliott HL. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. J Cardiovasc Pharmacol. 1994;23(Suppl 5):S26–30. - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. - PubMed

Publication types

MeSH terms

Substances